Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp108 | Diabetes Translational | ECE2018

The effect of GLP-1 agonist treatment on serum betatrophin levels and comparison with insülin treatment in type 2 diabetes mellitus patients

Tarkun Ilhan , Cakmak Yagmur , Akyay Zeynep , Selek Alev , Canturk Zeynep , Cetinarslan Berrin

Objective: Insulin insufficiency which is the result of deficiency of β-cells is the common feature for all types of diabetes. Therefore protection of functional β-cell mass is the keystone of diabetes treatment. Betatrophin, a newly determined hormone, has been identified as a potent stimulator that increases the production and expansion of β-cells in mice. However, very little is known about the physiological role of betatrophin in h...